ECSP003416A - NEW ANDROGENS ORALLY ACTIVE ASSETS DERIVED FROM 7BETA- METHYL-19- NORTESTOSTERONE - Google Patents

NEW ANDROGENS ORALLY ACTIVE ASSETS DERIVED FROM 7BETA- METHYL-19- NORTESTOSTERONE

Info

Publication number
ECSP003416A
ECSP003416A ECSP003416A ECSP003416A EC SP003416 A ECSP003416 A EC SP003416A EC SP003416 A ECSP003416 A EC SP003416A EC SP003416 A ECSP003416 A EC SP003416A
Authority
EC
Ecuador
Prior art keywords
alkyl
nortestosterone
methyl
orally active
7beta
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Dirk Leysen
Van Der Jaap Louw
Bursi Roberta Buma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003416 priority Critical patent/ECSP003416A/en
Publication of ECSP003416A publication Critical patent/ECSP003416A/en

Links

Landscapes

  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se relaciona con nuevos andrógenos oralmente activos derivados de 7a-metil-19-nortestosterona. Los compuestos satisfacen la fórmula general donde R1 es (O, H,H), (H,OR), NOR siendo R hidrógeno, (c1-6) alquilo, isopropilo, (c2-3) alquilo, isopropilo, 1,2-propadienilo o (c2-3) 1-alquinilo, cada uno opcionalmente sustituido por halógeno; o R2 es ciclopropilo o ciclopropenilo, cada uno opcionalmente sustituido por (C1-2) alquilo o halógeno; R3 es hidrógeno (C1-2) alquilo o etinilo; R4 es (C1-2)alquilo; R5 es hidrógeno o (C1-15) acilo; y las lineas de puntos indican enlaces opcionales.The invention relates to novel orally active androgens derived from 7a-methyl-19-nortestosterone. The compounds satisfy the general formula where R1 is (O, H, H), (H, OR), NOR where R is hydrogen, (C1-6) alkyl, isopropyl, (c2-3) alkyl, isopropyl, 1,2- propadienyl or (c2-3) 1-alkynyl, each optionally substituted by halogen; or R2 is cyclopropyl or cyclopropenyl, each optionally substituted by (C1-2) alkyl or halogen; R3 is hydrogen (C1-2) alkyl or ethynyl; R4 is (C1-2) alkyl; R5 is hydrogen or (C1-15) acyl; and the dotted lines indicate optional links.

ECSP003416 2000-04-06 2000-04-06 NEW ANDROGENS ORALLY ACTIVE ASSETS DERIVED FROM 7BETA- METHYL-19- NORTESTOSTERONE ECSP003416A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003416 ECSP003416A (en) 2000-04-06 2000-04-06 NEW ANDROGENS ORALLY ACTIVE ASSETS DERIVED FROM 7BETA- METHYL-19- NORTESTOSTERONE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003416 ECSP003416A (en) 2000-04-06 2000-04-06 NEW ANDROGENS ORALLY ACTIVE ASSETS DERIVED FROM 7BETA- METHYL-19- NORTESTOSTERONE

Publications (1)

Publication Number Publication Date
ECSP003416A true ECSP003416A (en) 2000-07-21

Family

ID=42041045

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003416 ECSP003416A (en) 2000-04-06 2000-04-06 NEW ANDROGENS ORALLY ACTIVE ASSETS DERIVED FROM 7BETA- METHYL-19- NORTESTOSTERONE

Country Status (1)

Country Link
EC (1) ECSP003416A (en)

Similar Documents

Publication Publication Date Title
AR024746A1 (en) ORALALLY ACTIVE ANDROGENS.
NO20071642L (en) N-Benzenesulfonyl-substituted anilino-pyrimidine analogs
HRP20080664A2 (en) SUBSTITUTED PYRIDINE HERBICIDES
SE0100902D0 (en) Compounds
DK1177176T3 (en) Triarylic acid derivatives as PPAR receptor ligands
CY1105233T1 (en) 1,2,4-THIADIAZOLE CATION DERIVATIVES AS MELANOCORTIN RECEPTOR REGULATORS
CY1106247T1 (en) THIOPHEN- AND THIAZOLESULFONAMIDES AS ANTINEOPLASTIC AGENTS
NO20041493L (en) Chemical connections.
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
CY1105907T1 (en) NEW 1,2,4-THIADIAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR REGULATORS
FI970246A7 (en) Dihydrobenzofurans
ES2182234T3 (en) METALOPROTEASE INHIBITORS.
TR200101709T2 (en) Compounds useful in the treatment of inflammatory diseases
DE122010000035I2 (en) SUBSTITUTED THIEN-3-YL-SULFONYLAMINO (THIO) CARBONYL-TRIAZOLINE (THI) ONE
DK1489090T3 (en) Hitherto unknown pseudoerythromycin derivatives
EA200301100A1 (en) NEW PHTHALASINOSES
DE50002836D1 (en) SUBSTITUTED ANILINE COMPOUNDS
DE60131967D1 (en) Nr1h4 nuclear receptor binding compounds
NO20043016L (en) 6-aminomorphinan derivatives, process for preparation and use thereof
NO20034667L (en) Arylsulfonamides as antivirals
ATE411287T1 (en) NEW METALPROTEINASE INHIBITORS
DK1086096T3 (en) Benzamides with tetrahydrofuranyloxy substituents as inhibitors of phosphodiesterase 4
DK1377574T3 (en) 6-phenylbenzonaphthyridines
CY1108837T1 (en) New aminopyridine derivatives as mGluR5 antagonists
BRPI0416678A (en) pyrazolpyrimidines